Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
34.65
+0.24 (0.70%)
At close: Nov 20, 2024, 4:00 PM
34.80
+0.15 (0.43%)
After-hours: Nov 20, 2024, 5:42 PM EST
Exelixis Market Cap
Exelixis has a market cap or net worth of $9.90 billion as of November 21, 2024. Its market cap has increased by 50.74% in one year.
Market Cap
9.90B
Enterprise Value
8.90B
1-Year Change
50.74%
Ranking
Category
Stock Price
$34.65
Market Cap Chart
Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $9.90B, an increase of 1,468.69%. That is a compound annual growth rate of 11.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 9.90B | 32.64% |
Dec 29, 2023 | 7.46B | 44.19% |
Dec 30, 2022 | 5.17B | -10.54% |
Dec 31, 2021 | 5.78B | -7.11% |
Dec 31, 2020 | 6.23B | 16.30% |
Dec 31, 2019 | 5.35B | -8.96% |
Dec 31, 2018 | 5.88B | -34.61% |
Dec 29, 2017 | 8.99B | 110.58% |
Dec 30, 2016 | 4.27B | 233.29% |
Dec 31, 2015 | 1.28B | 355.89% |
Dec 31, 2014 | 281.10M | -75.11% |
Dec 31, 2013 | 1.13B | 34.59% |
Dec 31, 2012 | 839.00M | 36.62% |
Dec 30, 2011 | 614.10M | -31.37% |
Dec 31, 2010 | 894.80M | 13.07% |
Dec 31, 2009 | 791.40M | 49.29% |
Dec 31, 2008 | 530.10M | -41.23% |
Dec 31, 2007 | 902.00M | 4.64% |
Dec 29, 2006 | 862.00M | 10.08% |
Dec 30, 2005 | 783.10M | 10.19% |
Dec 31, 2004 | 710.70M | 41.83% |
Dec 31, 2003 | 501.10M | 9.05% |
Dec 31, 2002 | 459.50M | -44.16% |
Dec 31, 2001 | 822.90M | 25.02% |
Dec 29, 2000 | 658.20M | 4.34% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vaxcyte | 10.71B |
Catalent | 10.71B |
Sarepta Therapeutics | 10.59B |
Medpace Holdings | 10.11B |
Encompass Health | 9.97B |
Exact Sciences | 9.75B |
Charles River Laboratories International | 9.61B |
Revolution Medicines | 9.60B |